Another benefit of reduced appetite is spending less money on food, whether thats buying groceries or going out to eat
This reflects the state of play as of early 2026: States that cover GLP-1s for obesity treatment (fee-for-service): Arkansas, Colorado, Connecticut, Delaware, Illinois, Louisiana, Massachusetts, Minnesota, New Mexico, New York, Oregon, Virginia, Washington approximately 13 states total as of January 2026
investment firm Platinum Equity
Clinically Formulated Peptide Therapy for Growth Hormone Support, Recovery, and Anti-Aging CJC-1295 and Ipamorelin are two synergistic peptides that work together to stimulate the bodys natural production of growth hormone (GH) without disrupting the bodys natural feedback mechanisms
Today we break down what was announced, which peptides are on the agenda, and what the regulatory pathway actually means